143 related articles for article (PubMed ID: 24178639)
1. L-Arginine inhibits in vitro nonenzymatic glycation and advanced glycosylated end product formation of human serum albumin.
Servetnick DA; Bryant D; Wells-Knecht KJ; Wiesenfeld PL
Amino Acids; 1996 Mar; 11(1):69-81. PubMed ID: 24178639
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Barnaby OS; Wa C; Cerny RL; Clarke W; Hage DS
Clin Chim Acta; 2010 Aug; 411(15-16):1102-10. PubMed ID: 20394739
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.
Barnaby OS; Cerny RL; Clarke W; Hage DS
Clin Chim Acta; 2011 Aug; 412(17-18):1606-15. PubMed ID: 21601565
[TBL] [Abstract][Full Text] [Related]
4. Potassium sorbate as an AGE activator for human serum albumin in the presence and absence of glucose.
Taghavi F; Moosavi-Movahedi AA; Bohlooli M; Hadi Alijanvand H; Salami M; Maghami P; Saboury AA; Farhadi M; Yousefi R; Habibi-Rezaei M; Sheibani N
Int J Biol Macromol; 2013 Nov; 62():146-54. PubMed ID: 24001567
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Potential of Carnosine and Aminoguanidine Towards Glycation and Fibrillation of Albumin: In-vitro and Simulation Studies.
Khan MR; Khan MS; Manoharan R; Karthikeyan S; Alhosaini K; Odeibat HAM; Ahmad MDI; Al-Okail M; Al-Twaijry N
J Fluoresc; 2023 Nov; ():. PubMed ID: 37971607
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
Ahmed N; Thornalley PJ
Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity.
Jakus V; Hrnciarová M; Cársky J; Krahulec B; Rietbrock N
Life Sci; 1999; 65(18-19):1991-3. PubMed ID: 10576452
[TBL] [Abstract][Full Text] [Related]
8. Formation of the molten globule-like state during prolonged glycation of human serum albumin.
Sattarahmady N; Moosavi-Movahedi AA; Ahmad F; Hakimelahi GH; Habibi-Rezaei M; Saboury AA; Sheibani N
Biochim Biophys Acta; 2007 Jun; 1770(6):933-42. PubMed ID: 17368729
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.
Abordo EA; Thornalley PJ
Immunol Lett; 1997 Aug; 58(3):139-47. PubMed ID: 9293394
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
Miyata T; Ueda Y; Asahi K; Izuhara Y; Inagi R; Saito A; VAN Ypersele DE Strihou C; Kurokawa K
J Am Soc Nephrol; 2000 Sep; 11(9):1719-1725. PubMed ID: 10966497
[TBL] [Abstract][Full Text] [Related]
11. Capillary zone electrophoresis and capillary electrophoresis-mass spectrometry for analyzing qualitative and quantitative variations in therapeutic albumin.
Marie AL; Przybylski C; Gonnet F; Daniel R; Urbain R; Chevreux G; Jorieux S; Taverna M
Anal Chim Acta; 2013 Oct; 800():103-10. PubMed ID: 24120174
[TBL] [Abstract][Full Text] [Related]
12. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Wa C; Cerny RL; Clarke WA; Hage DS
Clin Chim Acta; 2007 Oct; 385(1-2):48-60. PubMed ID: 17707360
[TBL] [Abstract][Full Text] [Related]
13. Effect of aminoguanidine and copper(II) ions on the formation of advanced glycosylation end products. In vitro study on human serum albumin.
Jakus V; Bauerová K; Rietbrock N
Arzneimittelforschung; 2001; 51(4):280-3. PubMed ID: 11367867
[TBL] [Abstract][Full Text] [Related]
14. Chicken albumin exhibits natural resistance to glycation.
Zuck J; Borges CR; Braun EJ; Sweazea KL
Comp Biochem Physiol B Biochem Mol Biol; 2017 Jan; 203():108-114. PubMed ID: 27773732
[TBL] [Abstract][Full Text] [Related]
15. Effect of nonenzymatic glycation of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro.
Chiou YJ; Tomer KB; Smith PC
Chem Biol Interact; 1999 Jul; 121(2):141-59. PubMed ID: 10418961
[TBL] [Abstract][Full Text] [Related]
16. The noncovalent conjugations of human serum albumin (HSA) with MS/AK and the effect on anti-oxidant capacity as well as anti-glycation activity of Monascus yellow pigments.
Wu S; Sun Y; Chen D; Liu H; Li Z; Chen M; Wang C; Cheng L; Guo Q; Peng X
Food Funct; 2021 Apr; 12(8):3692-3704. PubMed ID: 33900309
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of advanced protein glycation by 8-quinolinecarboxylic hydrazide.
Miwa I; Tsugawa T; Koyasu K; Terada Y
Pharmacology; 1996 May; 52(5):314-20. PubMed ID: 8807675
[TBL] [Abstract][Full Text] [Related]
19. Methylglyoxal induced glycation and aggregation of human serum albumin: Biochemical and biophysical approach.
Ahmed A; Shamsi A; Khan MS; Husain FM; Bano B
Int J Biol Macromol; 2018 Jul; 113():269-276. PubMed ID: 29481950
[TBL] [Abstract][Full Text] [Related]
20. The anti-apoptotic activity of albumin for endothelium is inhibited by advanced glycation end products restricting intramolecular movement.
Zoellner H; Siddiqui S; Kelly E; Medbury H
Cell Mol Biol Lett; 2009; 14(4):575-86. PubMed ID: 19484197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]